| ORIGINAL ARTICLE |
|
| Year : 2018 | Volume
: 14
| Issue : 7 | Page : 1578-1582 |
|
|
Diagnosis and treatment of hemangiopericytoma in the central nervous system
Fang Liu1, Boning Cai1, Yu Du2, Yurong Huang1
1 Department of Radiation Oncology, Chinese PLA General Hospital, Beijing, China
2 Department of Radiation Oncology, First Affiliated Hospital of PLA General Hospital, Beijing, China
Correspondence Address:
Fang Liu
Department of Radiation Oncology, Chinese PLA General Hospital, No. 28, Fuxing Road, Beijing-100853
China
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/jcrt.JCRT_210_18
|
|
|
Objective: This study aimed to explore the clinical characteristics and treatment of the hemangiopericytoma (HPC) in the central nervous system.
Materials and Methods: Clinical data from 14 patients with HPC in the central nervous system who were followed up for 12–107 months were retrospectively analyzed, and relevant literature was reviewed.
Results: All 14 patients underwent surgery and postoperative pathologic diagnosis, including 8 cases of total excision, 3 cases of subtotal excision, and 3 cases of partial excision. There were 7 recurrent cases (50%, 4 cases of total excision, 1 case of subtotal excision, and 2 cases of partial excision, none of them received postoperative radiotherapy) with a median relapse time of 39 months, where the median relapse time after total excision was 41.5 months, and after nontotal excision was 17 months. In addition, patients could survive for a long time after reoperation following relapse and after receiving postoperative radiotherapy.
Conclusion: The diagnosis of HPC depends on the pathology. Currently, the surgery and postoperative radiotherapy provide a good treatment results, while the wholeness of surgical resection is of particular importance.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
